Free exam prep

ABIM Internal Medicine

11.3 Bipolar Disorder, Mood Stabilizers & Lithium Toxicity

Q: A 46-year-old woman with Bipolar I disorder maintained on Lithium Carbonate 600 mg BID (with a stable baseline serum level of 0.8 mEq/L) presents to the emergency department with severe nausea, persistent vomiting, coarse bilateral hand tremors, unsteady gait, slurred speech, and progressive confusion over the past 2 days. Her family reports that 5 days ago, she developed acute right knee pain from osteoarthritis and began taking over-the-counter high-dose ibuprofen (800 mg three times daily). On physical examination, temperature is 36.8°C (98.2°F), blood pressure is 108/68 mmHg, heart rate is 62 bpm, and dry mucous membranes are noted. Neurological examination reveals marked bilateral horizontal nystagmus, dysmetria on finger-to-nose testing, generalized hyperreflexia (3+ patellar reflexes), and wide-based ataxia. Laboratory testing reveals: BUN 38 mg/dL, Serum Creatinine 2.2 mg/dL (baseline 0.9 mg/dL), Serum Sodium 138 mEq/L, Serum Potassium 4.1 mEq/L, and Serum Lithium level 2.8 mEq/L. Which of the following is the most appropriate management strategy?

Discontinue Lithium and Ibuprofen immediately, initiate aggressive IV 0.9% Normal Saline hydration, and monitor serial lithium levels and renal function in the intensive care unit. This patient presents with moderate-to-severe lithium toxicity (serum level 2.8 mEq/L) precipitated by the initiation of high-dose Ibuprofen (an NSAID). NSAIDs inhibit renal prostaglandin synthesis, leading to decreased renal blood flow, reduced glomerular filtration rate (GFR), and decreased renal excretion of lithium (which is 100% renally cleared), causing rapid lithium accumulation. Dehydration from vomiting further diminishes GFR. The initial management of lithium toxicity includes immediate cessation of lithium and the offending NSAID, followed by aggressive IV hydration with isotonic crystalloids (0.9% Normal Saline at 150-200 mL/h). Saline expansion restores intravascular volume, enhances renal blood flow, and promotes lithium clearance through the proximal renal tubules. The patient should be admitted to the ICU with continuous telemetry and serial lithium levels checked every 2-4 hours. Emergent hemodialysis is indicated for serum lithium levels >4.0 mEq/L regardless of clinical status, or for levels >2.5 mEq/L when accompanied by severe life-threatening neurological complications (e.g., status epilepticus, profound coma), intractable hemodynamic instability, or worsening acute renal failure refractory to aggressive saline hydration. In this hemodynamically stable patient without seizures or coma, aggressive IV saline hydration is the correct initial intervention while preparing for potential hemodialysis if levels fail to decline. Activated charcoal does not bind lithium ions (which are small inorganic cations). Physostigmine is for anticholinergic toxicity, not lithium toxicity.

Key Takeaways

Bipolar I requires a manic episode, while bipolar II requires hypomania with a major depressive episode and no history of mania.
Lithium toxicity is precipitated by volume depletion, non-steroidal anti-inflammatory drugs, thiazides and angiotensin-converting enzyme inhibitors.
Severe lithium toxicity with neurologic impairment or kidney failure is treated with hemodialysis.
Lithium causes nephrogenic diabetes insipidus, chronic tubulointerstitial disease and hypothyroidism, requiring periodic monitoring.
Valproate is contraindicated in people who may become pregnant because of neural tube defects and adverse neurodevelopmental outcomes.

Last updated: August 2026

1. Bipolar Disorder: Classification, Mood Stabilizers & Lithium Toxicity

Bipolar disorder is characterized by pathological fluctuations in mood, energy, and activity levels. Accurate differentiation from unipolar depression is critical, as incorrect pharmacotherapy can trigger life-threatening mania.

Diagnostic Distinction: Bipolar I vs. Bipolar II vs. Cyclothymia

Diagnostic Category	Diagnostic Criteria & Episode Characteristics	Psychosis & Hospitalization	Functional Impairment
Bipolar I Disorder	>=1 Lifetime Manic Episode (major depressive episode is common but not required for diagnosis). Manic episode: Distinct period of abnormally and persistently elevated, expansive, or irritable mood + increased goal-directed activity lasting >= 1 week (or any duration if hospitalization is necessary), with >=3 DIG FAST symptoms (>=4 if mood is irritable)	Psychotic features (delusions, hallucinations) may be present; frequently requires emergent hospitalization	Severe impairment in social, occupational, or interpersonal functioning
Bipolar II Disorder	>=1 Hypomanic Episode AND >=1 Major Depressive Episode; must NEVER have had a full manic episode. Hypomanic episode: Lasts >= 4 consecutive days with >=3 DIG FAST symptoms; clear change from baseline observable by others	NO psychotic features; does NOT require hospitalization	Unequivocal change in functioning, but does NOT cause severe social or occupational impairment
Cyclothymic Disorder	Chronic, fluctuating mood disturbance lasting >= 2 years in adults (>=1 year in adolescents) with numerous periods of hypomanic symptoms and depressive symptoms that do not meet full criteria for hypomania or major depression	No psychosis; no hospitalization	Mild-to-moderate chronic distress and functional impairment

DSM-5 Manic Symptom Mnemonic: "DIG FAST"
--------------------------------------------------------------------------
D — Distractibility (attention easily drawn to unimportant external stimuli)
I — Indiscretion / Impulsivity (excessive involvement in high-risk activities: spending sprees, sexual indiscretions, reckless driving)
G — Grandiosity (inflated self-esteem, delusions of special power, wealth, or identity)
F — Flight of ideas (subjective experience that thoughts are racing; rapid topic shifting)
A — Activity increase (increased goal-directed activity socially, at work, or sexually) or psychomotor agitation
S — Sleep decreased need (feels fully rested and energized after only 2 to 3 hours of sleep)
T — Talkativeness (pressured, rapid, loud speech that is difficult or impossible to interrupt)
--------------------------------------------------------------------------

CRITICAL ABIM BOARD SAFETY RULE: Antidepressant Monotherapy in Bipolar Disorder Initiating antidepressant monotherapy (SSRIs, SNRIs, TCAs, Bupropion) in a patient with Bipolar I or Bipolar II disorder is strictly contraindicated. Antidepressant monotherapy carries a high risk of precipitating an acute switch into mania or hypomania, triggering mixed states, or accelerating rapid cycling (>4 mood episodes/year). In bipolar depression, mood stabilizers or approved atypical antipsychotics must always be used as first-line therapy.

First-Line Mood Stabilizer Pharmacology & Monitoring

1. Lithium Carbonate

Mechanism of Action: Alters transmembrane cation transport; inhibits inositol monophosphatase (depleting neuronal second-messenger PIP2); inhibits Glycogen Synthase Kinase-3 (GSK-3beta); promotes neurogenesis and neuroprotection.
Efficacy: Gold-standard mood stabilizer for acute mania, bipolar maintenance, and bipolar depression; proven to reduce suicide mortality and completed suicide rates by >5-fold in bipolar and recurrent unipolar depression.
Therapeutic Serum Levels (12-hour trough level):
- Acute Mania: 0.8 to 1.2 mEq/L
- Long-Term Maintenance: 0.6 to 0.8 mEq/L (elderly: 0.4 to 0.6 mEq/L)
Mandatory Baseline & Routine Monitoring:
- Renal Function (BUN, Serum Creatinine, eGFR): Lithium is 100% cleared by the kidneys; monitor every 3-6 months.
- Thyroid Function (TSH, Free T4): Lithium inhibits thyroid hormone synthesis and release (causes benign goiter and hypothyroidism in 15-20% of patients; manage by adding Levothyroxine, do not discontinue lithium).
- Serum Calcium: Lithium alters calcium-sensing receptors, causing hyperparathyroidism and hypercalcemia; monitor annually.
- Urinalysis: Screen for Nephrogenic Diabetes Insipidus (NDI) (polyuria, polydipsia, low urine osmolality <300 mOsm/kg despite water deprivation; lithium enters principal cells via ENaC channels and disrupts aquaporin-2 expression; treated with Amiloride which blocks ENaC, plus thiazides/indomethacin).
- Baseline 12-Lead ECG: T-wave flattening, sinus node dysfunction.
- Pregnancy Test (beta-hCG): First-trimester exposure carries an elevated risk of Ebstein Anomaly (apical displacement of the tricuspid valve leaflets, atrialization of the right ventricle, tricuspid regurgitation; absolute risk ~1 in 1000 live births vs 1 in 20,000 baseline).

Lithium Toxicity Clinical Manifestations & Hemodialysis Triggers

Toxicity Severity & Serum Level	Clinical Signs & Neurological Manifestations	Precipitating Factors & Drug-Drug Interactions	Management Protocol
Mild-to-Moderate Toxicity; (1.5 to 2.0 mEq/L)	Coarse hand tremor, muscular weakness, ataxia, dysarthria, sluggishness, lethargy, persistent nausea, vomiting, watery diarrhea	Dehydration, volume depletion, fever, reduced oral fluid intake, low-sodium diets	Discontinue lithium; obtain stat serum lithium level, CMP, and ECG; administer IV 0.9% Normal Saline at 150-200 mL/h to restore GFR
Moderate-to-Severe Toxicity; (2.0 to 2.5 mEq/L)	Coarse tremor, profound ataxia, hyperreflexia, muscle fasciculations, myoclonus, confusion, delirium, visual hallucinations, flat affect	Drug Interactions that Impair Renal Lithium Excretion:; 1. NSAIDs (ibuprofen, naproxen, celecoxib; reduce renal prostaglandin synthesis -> decrease renal blood flow and GFR); 2. ACE Inhibitors & ARBs (lisinopril, losartan; decrease GFR); 3. Thiazide Diuretics (hydrochlorothiazide, chlorthalidone; promote sodium loss in distal tubule -> compensatory proximal reabsorption of Na and Li); (Note: Aspirin and Sulindac have minimal effect on lithium levels)	ICU admission; aggressive IV 0.9% Normal Saline volume resuscitation; continuous telemetry; avoid forced diuresis with loop diuretics
Severe Life-Threatening Toxicity; (> 2.5 mEq/L or > 4.0 mEq/L)	Seizures, status epilepticus, non-convulsive status, generalized hypertonia, stupor, coma, ventricular arrhythmias, circulatory collapse, acute oliguric renal failure, death	Severe acute overdose, acute-on-chronic ingestion, severe renal failure	EMERGENT HEMODIALYSIS INDICATIONS:; 1. Serum Lithium Level > 4.0 mEq/L regardless of clinical symptoms.; 2. Serum Lithium Level > 2.5 mEq/L in the presence of severe neurological toxicity (seizures, coma, marked delirium) or acute renal failure.; 3. Hemodynamically unstable patient or lithium levels continuing to rise despite IV saline hydration. (Note: Continue HD until level is <1.0 mEq/L; monitor for post-dialysis rebound release from intracellular stores)

Test Your Knowledge

A 46-year-old woman with Bipolar I disorder maintained on Lithium Carbonate 600 mg BID (with a stable baseline serum level of 0.8 mEq/L) presents to the emergency department with severe nausea, persistent vomiting, coarse bilateral hand tremors, unsteady gait, slurred speech, and progressive confusion over the past 2 days. Her family reports that 5 days ago, she developed acute right knee pain from osteoarthritis and began taking over-the-counter high-dose ibuprofen (800 mg three times daily). On physical examination, temperature is 36.8°C (98.2°F), blood pressure is 108/68 mmHg, heart rate is 62 bpm, and dry mucous membranes are noted. Neurological examination reveals marked bilateral horizontal nystagmus, dysmetria on finger-to-nose testing, generalized hyperreflexia (3+ patellar reflexes), and wide-based ataxia. Laboratory testing reveals: BUN 38 mg/dL, Serum Creatinine 2.2 mg/dL (baseline 0.9 mg/dL), Serum Sodium 138 mEq/L, Serum Potassium 4.1 mEq/L, and Serum Lithium level 2.8 mEq/L. Which of the following is the most appropriate management strategy?

Administer oral activated charcoal, IV potassium chloride, and continue lithium at a 50% dose reduction

Administer IV Physostigmine for suspected anticholinergic toxicity and perform emergent gastric lavage

Perform emergent hemodialysis immediately, as any lithium level above 2.0 mEq/L is an absolute indication for renal replacement therapy

Discontinue Lithium and Ibuprofen immediately, initiate aggressive IV 0.9% Normal Saline hydration, and monitor serial lithium levels and renal function in the intensive care unit

Sections you finish are checked off in the contents.

Up Next

11.4 Anxiety, Stress-Related & Obsessive-Compulsive Disorders

Continue learning